A Review of Chemotherapy for Locally Advanced Head and Neck Cancers

AuthorMohammad Shabanien
AuthorMohammad Hassan Larizadehen
Issued Date2015-01-28en
AbstractContext:: Chemoradiation provides a survival advantage as well as increased rate of organ preservation compared with radiation alone in locally advanced head and neck squamous cell carcinoma (LAHNSCC). Evidence Acquisition:: Combined modality protocols can be used in 3 forms: a) induction chemotherapy or neoadjuvant therapy before definitive surgery or radiotherapy, b) Concurrent chemo- radiotherapy, and c) sequential therapy consisting of induction chemotherapy followed by concurrent chemo radiation. Results:: Despite an improvement in organ preservation, induction treatment has no impact on survival. Ongoing phase III trials comparing sequential therapy with concurrent chemoradiation may establish which of these two approaches is superior. Conclusions:: Until those trials have been completed, Taxane- based sequentional therapy can be a reasonable alternative to concurrent chemo radiotherapy in the patients with locally advanced disease.en
DOIhttps://doi.org/10.5812/rro.2(1)2015.2261en
KeywordRadiotherapyen
KeywordHead and Neck Neoplasmsen
KeywordChemotherapyen
PublisherBrieflandsen
TitleA Review of Chemotherapy for Locally Advanced Head and Neck Cancersen
TypeReview Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
rro-02-2261.pdf
Size:
123.99 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF